Guided fluid removal using VeXUS score for patients with acute kidney injury after heart surgery
Official title: Feasibility of a Randomised Trial Comparing a Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery: a Pilot Randomised Trial.
Run by Hospices Civils de Lyon · NCT06251713 · Data updated 2026-11-12
This study is testing if using the VeXUS score to manage fluid levels can help patients with acute kidney injury after heart surgery recover better than standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 2 sites (Bron, Bron and 1 other locations) |
| Status | Recruiting |
| Started | July 31, 2024 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT06251713 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients admitted to the ICU within 72 hours of cardiac surgery who meet the KDIGO criteria for acute kidney injury.
✕Probably not a fit
Patients with severe pre-existing kidney disease or those requiring immediate renal replacement therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of the VeXUS score, an ultrasound-based assessment of venous congestion, to guide fluid management in patients who have developed acute kidney injury following cardiac surgery. The goal is to determine if this targeted approach can improve patient outcomes compared to standard care. Participants will be those admitted to the intensive care unit within 72 hours post-surgery and diagnosed with acute kidney injury. The study aims to address the challenges of fluid management in this vulnerable population, where both dehydration and fluid overload can be harmful.
Why it matters
Potential benefit: If successful, this approach could lead to improved kidney recovery and reduced mortality in patients after cardiac surgery.
How similar studies have gone: While the use of ultrasound scores in fluid management is gaining traction, this specific application of the VeXUS score is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Intensive care unit admission within 72 hours of cardiac surgery with extracorporeal circulation * Acute kidney injury defined by KDIGO criteria * Vasoactive inotropic score \<45 and capillary refill time \<3s * Informed written consent Exclusion Criteria: * Hypokalaemia \<3.5mmol/L * Hyponatremia\<125mmol/L * Hypernatremia \>145mmol/L * Metabolic alkalosis with pH \>7.50 * Impossibility to measure capillary refill time * Chronic liver disease * Cirrhosis with portal hypertension * Known thrombus of the inferior vena cava * Mechanical circulatory assistance (ECMO or mono left ventricular assistance) * Severe pre-operative chronic kidney disease (GFR \< 30mL/min/1.73m2) * Need for renal replacement therapy anticipated by the attending physician within 24 hours * Known hypersensitivity to Furosemide and/or hydrochlorothiazide * Severe allergy to wheat * Patient already included in another interventional study with an exclusion period still in progress * Pregnant, breast-feeding or women of childbearing age without suitable contraception * Patients under guardianship, curatorship or safeguard of justice * Patients under psychiatric care * Patients not affiliated to a social security scheme or beneficiaries of a similar scheme
Where it's running
-
Hopital cardiologique Louis Pradel
Bron, France Recruiting -
Hôpital Louis Pradel, Groupement Hospitalier Est, Hospices Civils de Lyon
Bron, Bron, France Not yet recruiting
Study contacts
- Study coordinator: Jean-Luc Fellahi, MD
- Email: jean-luc.fellahi@chu-lyon.fr
- Phone: +334 72 31 89 44
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcutaneous auricular vagus nerve stimulation to prevent kidney injury after heart surgery
This trial tests whether applying a non-invasive ear stimulation (taVNS) around the time of elective heart surgery can help prevent acute kidney injury in adults undergoing cardiopulmonary bypass.
-
Venous congestion and delirium after heart surgery
This project will see if venous congestion during and after elective heart surgery is linked to a higher risk of postoperative delirium in adults who can complete cognitive testing.
-
Using LSALT peptide to prevent kidney injury in heart surgery patients
This study is testing if a new peptide can help prevent kidney injury in patients having heart surgery.
-
Investigating the role of angiopoietins in cardiac surgery outcomes
This study is trying to see if measuring certain proteins in the blood can help predict complications for adults having heart surgery.
-
Impact of Fast-Track Anesthesia on Postoperative Delirium After Cardiac Surgery
This observational study tests whether fast-track anesthesia, compared with conventional care, is linked to lower rates of delirium after elective cardiac surgery in adults.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.